4//SEC Filing
Safier Jacob 4
Accession 0000921895-24-002878
CIK 0001460602other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:48 PM ET
Size
23.8 KB
Accession
0000921895-24-002878
Insider Transaction Report
Form 4
Orgenesis Inc.ORGS
Safier Jacob
10% Owner
Transactions
- Purchase
Common Stock
2024-04-16$0.51/sh+10,000$5,135→ 3,120,100 total(indirect: By LLC) - Sale
Common Stock
2024-06-24$0.58/sh−10,000$5,814→ 3,110,100 total(indirect: By LLC) - Award
Warrant (right to buy)
2024-09-09+242,718→ 242,718 totalExercise: $1.03From: 2024-09-09Exp: 2029-09-08→ Common Stock (242,718 underlying) - Purchase
Common Stock
2024-04-10$0.59/sh+10,000$5,948→ 3,120,100 total(indirect: By LLC) - Sale
Common Stock
2024-04-10$0.54/sh−10,000$5,444→ 3,110,100 total(indirect: By LLC) - Sale
Common Stock
2024-04-16$0.50/sh−10,000$5,001→ 3,110,100 total(indirect: By LLC) - Purchase
Common Stock
2024-06-24$0.58/sh+10,000$5,800→ 3,120,100 total(indirect: By LLC) - Award
Warrant (right to buy)
2024-08-21+970,873→ 970,873 totalExercise: $1.03From: 2024-08-21Exp: 2029-08-20→ Common Stock (970,873 underlying) - Award
Warrant (right to buy)
2024-11-04+242,718→ 242,718 totalExercise: $1.03From: 2024-11-04Exp: 2029-11-03→ Common Stock (242,718 underlying)
Holdings
- 2,000,000
Common Stock
Footnotes (8)
- [F1]On September 25, 2024, the Issuer effected a reverse stock split at a ratio of 1-for-10. The share amounts set forth here are presented before giving effect to the reverse stock split.
- [F2]The Reporting Person is the portfolio manager of the investment in the Issuer by JSAF Holdings, LLC ("JSAF") and may therefore be deemed to beneficially own the shares owned by JSAF. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Pursuant to an Amended and Restated Promissory Note, dated as of August 10, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 1") exercisable for 970,873 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
- [F4]Other than 53,970 shares currently exercsiable, Warrant 1 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
- [F5]Pursuant to an Amended and Restated Promissory Note, dated as of September 9, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 2") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
- [F6]Warrant 2 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
- [F7]Pursuant to an Amended and Restated Promissory Note, dated as of November 4, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 3") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
- [F8]Warrant 3 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
Documents
Issuer
Orgenesis Inc.
CIK 0001460602
Entity typeother
Related Parties
1- filerCIK 0001381740
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 6:48 PM ET
- Size
- 23.8 KB